* Novartis also picks top scientist to lead immuno-oncology (Adds details on Aduro's planned IPO, analyst comment)
March 30 (Reuters) - Swiss drugmaker Novartis is digging deeper into the world of cancer immunotherapy - one of the hottest areas of drug research - through a tie-up with California-based Aduro...
* Says accelerates cancer immunotherapy efforts with Aduro Biotech alliance and launch of new immuno-oncology research group.
LONDON, March 29 (Reuters) - GlaxoSmithKline has reached a deal with the British government to supply a new meningitis B vaccine, following a lengthy stand-off over price with the product's previous owner Novartis .
SAN FRANCISCO, March 25 (Reuters) - Amgen Inc will appeal the rejection of its bid to block the sale of Novartis AG 's biosimilar form of Neupogen, Amgen's blockbuster drug used to prevent infections...
* Novartis buys out CAD 106 license agreement for 4 million Swiss francs ($4 million)
* Up from three potential $1 billion-plus drugs in 2014 (Updates with link to report, paragraph 5)
drug manufacturer and solidified its ranking as a generics industry leader along with Teva, Sandoz (a subsidiary of Novartis NVS ), and Mylan. We estimate that these four companies have nearly 50% of the global retail generic industry market
LONDON, March 23 (Reuters) - Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion-plus sales potential, according to a Thomson Reuters analysis.
was purchase/volume guarantees for vaccines and contraceptive implants. “We would go to a Merck, a Bayer, a Novartis , an Indian vaccine manufacturer and say, ‘If you provide these volumes over this time, we’ll guarantee that